Larry C. Park

1.2k total citations
13 papers, 703 citations indexed

About

Larry C. Park is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Larry C. Park has authored 13 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Larry C. Park's work include Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Neurological disorders and treatments (7 papers). Larry C. Park is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Neurological disorders and treatments (7 papers). Larry C. Park collaborates with scholars based in United States, Finland and Netherlands. Larry C. Park's co-authors include David Howland, Afshin Ghavami, Mei Kwan, Carol A. Murphy, Dani Brunner, Kristi McConnell, Liliana Menalled, Sylvie Ramboz, Ignacio Muñoz-Sanjuán and Richard Mushlin and has published in prestigious journals such as PLoS ONE, Archives of Biochemistry and Biophysics and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Larry C. Park

13 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry C. Park United States 10 579 485 276 34 33 13 703
Alessia Tarditi Italy 9 543 0.9× 462 1.0× 183 0.7× 57 1.7× 44 1.3× 12 750
Outi Kontkanen Finland 11 385 0.7× 342 0.7× 144 0.5× 29 0.9× 16 0.5× 17 530
Marta Garcia‐Miralles Singapore 12 240 0.4× 322 0.7× 166 0.6× 66 1.9× 57 1.7× 21 515
Vincent Mittoux France 6 461 0.8× 377 0.8× 212 0.8× 32 0.9× 35 1.1× 6 588
Maricel Gómez‐Soler Spain 15 329 0.6× 411 0.8× 67 0.2× 32 0.9× 31 0.9× 22 611
Giulia Ponterio Italy 18 721 1.2× 305 0.6× 568 2.1× 35 1.0× 61 1.8× 30 928
Simon Z. East United Kingdom 5 248 0.4× 218 0.4× 214 0.8× 46 1.4× 30 0.9× 7 471
George J. Yohrling United States 15 669 1.2× 635 1.3× 198 0.7× 49 1.4× 24 0.7× 27 879
A. Mahal United Kingdom 7 829 1.4× 734 1.5× 341 1.2× 69 2.0× 52 1.6× 7 966
Steven K. Harmon United States 9 427 0.7× 436 0.9× 63 0.2× 43 1.3× 15 0.5× 11 625

Countries citing papers authored by Larry C. Park

Since Specialization
Citations

This map shows the geographic impact of Larry C. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry C. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry C. Park more than expected).

Fields of papers citing papers by Larry C. Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry C. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry C. Park. The network helps show where Larry C. Park may publish in the future.

Co-authorship network of co-authors of Larry C. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Larry C. Park. A scholar is included among the top collaborators of Larry C. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry C. Park. Larry C. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Heikkinen, Taneli, Timo Bragge, Teija Parkkari, et al.. (2020). Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington’s disease. PLoS ONE. 15(12). e0243052–e0243052. 17 indexed citations
2.
Ghavami, Afshin, Michael Olsen, Mei Kwan, et al.. (2020). Transcriptional Assessment of Striatal mRNAs as Valid Biomarkers of Disease Progression in Three Mouse Models of Huntington’s Disease. Journal of Huntington s Disease. 9(1). 13–31. 2 indexed citations
3.
Huhtala, Tuulia, Pekka Poutiainen, Jussi Rytkönen, et al.. (2019). Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI Radiopharmacy and Chemistry. 4(1). 20–20. 9 indexed citations
4.
Padovan‐Neto, Fernando E., Conor H. Murray, Grace E. Stutzmann, et al.. (2018). Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease. Nitric Oxide. 83. 40–50. 19 indexed citations
5.
Parkkari, Teija, Taneli Heikkinen, Jukka Puoliväli, et al.. (2018). Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task. Frontiers in Behavioral Neuroscience. 12. 226–226. 7 indexed citations
6.
Bresciani, Alberto, Antonino Missineo, Mariana Gallo, et al.. (2017). Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1). Archives of Biochemistry and Biophysics. 631. 31–41. 42 indexed citations
7.
Curtin, Paul, Andrew M. Farrar, Stephen Oakeshott, et al.. (2016). Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD. Frontiers in Behavioral Neuroscience. 9. 361–361. 27 indexed citations
8.
Naseri, Nima, Hui Xu, Larry C. Park, et al.. (2016). Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington’s Disease Patients. PLoS ONE. 11(9). e0160384–e0160384. 24 indexed citations
9.
Naseri, Nima, Hui Xu, Jean Paul Vonsattel, et al.. (2015). Abnormalities in the Tricarboxylic Acid Cycle in Huntington Disease and in a Huntington Disease Mouse Model. Journal of Neuropathology & Experimental Neurology. 74(6). 527–537. 42 indexed citations
10.
Farrar, Andrew M., Carol A. Murphy, Neil E. Paterson, et al.. (2014). Cognitive Deficits in Transgenic and Knock-in HTT Mice Parallel those in Huntington's Disease. Journal of Huntington s Disease. 3(2). 145–158. 14 indexed citations
11.
Murphy, Carol A., Neil E. Paterson, Dansha He, et al.. (2014). Cognitive Deficits in the R6/2 mouse model of Huntington’s disease and their Amelioration with Donepezil. International Journal of Comparative Psychology. 27(3). 3 indexed citations
12.
Heikkinen, Taneli, Kimmo Lehtimäki, Nina Vartiainen, et al.. (2012). Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease. PLoS ONE. 7(12). e50717–e50717. 188 indexed citations
13.
Menalled, Liliana, Andrea E. Kudwa, J. Fitzpatrick, et al.. (2012). Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175. PLoS ONE. 7(12). e49838–e49838. 309 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026